Atorvastatin Before Prostatectomy and Prostate Cancer
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
This single-center, randomized, double-blind trial assesses the impact of short-term
atorvastatin administration on proliferation activity, apoptotic rate and histological
inflammation in prostate tissue.
Phase:
Phase 2
Details
Lead Sponsor:
Tampere University Hospital
Collaborators:
Fimlab laboratories Finnish Cultural Foundation Tampere University University of Eastern Finland University of Tampere